2009
DOI: 10.2741/e31
|View full text |Cite
|
Sign up to set email alerts
|

The use of hormonal therapy in pediatric heart disease

Abstract: Introduction 3. The effects of tri-iodothyronine in the pediatric post-operative cardiac patients 3.1. Introduction 3.2. Regulation of thyroid hormone secretion and the mechanism of action 3.3. Changes to thyroid hormone metabolism following cardiac surgery 3.4. Trials of thyroid hormone supplementation in post-operative cardiac patients 4. Fludrocortisone treatment for syncope 4.1. Introduction 4.1. The mechanism of action of fludrocortisone 4.2. Treatment for syncope 5. Corticosteroids after cardiopulmonary … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 266 publications
(189 reference statements)
0
1
0
Order By: Relevance
“…Consequently, there is an abnormality of peptides, ions, and excitation-contraction coupling. There is an alteration in calcium ions' delivery to the contractile sites with consequent impaired cardiac performance [ 8 ]. B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are peptides produced in small amounts in the heart.…”
mentioning
confidence: 99%
“…Consequently, there is an abnormality of peptides, ions, and excitation-contraction coupling. There is an alteration in calcium ions' delivery to the contractile sites with consequent impaired cardiac performance [ 8 ]. B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are peptides produced in small amounts in the heart.…”
mentioning
confidence: 99%